Our leadership team
Our Board and operational leadership team drive the company forward.
President and Chief Executive Officer
Zlatko Rihter
Zlatko Rihter is a Swedish national and joined Mölnlycke in November 2020 as the President and CEO of Mölnlycke Health Care AB. He has extensive experience from the healthcare sector after having spent more than 20 years within the industry. Prior to joining Mölnlycke, he was President and CEO of Sweden-based CellaVision, a world-leading provider of digital solutions for medical microscopy in the field of hematology, listed on Nasdaq Nordic.
Previous positions include EVP Sales & Marketing at ORIGIO, as well as President GBU Chronic at Gambro and Director Patient Handling Product Division at ArjoHuntleigh.
EXECUTIVE VICE PRESIDENT Business Area OR Solutions
Anders Andersson
BORN: 1971
Nationality: Swedish
Anders is responsible for our focused OR (Operating Room) Solutions organization within the Mölnlycke Procedure Trays, staff clothing and drapes product ranges. Anders has been with the company since 2000. During the years with Mölnlycke he has held various senior roles in Operations, Commercial and R&D. Before taking on his current role, he was Vice President of Global Manufacturing and EVP OR Solutions.
Executive Vice President Business Area Gloves
Katriina Öberg
BORN: 1966
Nationality: Finnish
Katriina, a Finnish national, has grown her career with Mölnlycke since she joined in 1999. During her years at the company, she has held various senior leadership roles in our global and regional Commercial businesses, within both marketing and sales.
Most recently she was Regional Vice President APAC stationed in Singapore, where she moved after holding General Manager position in Region North.
Executive Vice President Business Area Antiseptics
Lina KarlssonBORN: 1973
Nationality: Swedish
Lina Karlsson leads our Antiseptics business. She joined Mölnlycke in April 2019 as head of ORS R&D, with a broad medtech and pharma background, much of which was at Gambro and Baxter. She has held senior global positions in R&D and Operations, with responsibility for a range of projects, including customer-focused innovation, cost optimisation, quality improvements, organisational development and integrations.
EXECUTIVE VICE PRESIDENT Business Area Wound Care
Rob Claypoole
BORN: 1971
Nationality: American
Rob is a US national and joined Mölnlycke in March 2017 as President, US. He was previously at Medtronic where he held various leadership roles including Global GM, Soft Tissue Repair and Global GM, Obesity & Metabolic Health and Executive Vice President Commercial. Before Medtronic, Rob held various marketing roles with increasing responsibility at Johnson & Johnson’s Vision Care division.
Chief Medical Officer & EXECUTIVE VICE PRESIDENT Regulatory and Quality Affairs
Emma Wright
BORN: 1973
Nationality: British
As our Chief Medical Officer, Emma is responsible for Clinical Affairs, Medical Affairs and Health Economics. She also leads the Regulatory Affairs and Quality Assurance teams. Emma joined Mölnlycke in 2018 and has spent her entire career in medical devices, particularly in the wound care and surgical implant space. She has worked across various markets, for a range of medtech businesses, from start-ups to large global companies.
Chief Operations Officer and EXECUTIVE VICE PRESIDENT Sustainability
Eric De Kesel
BORN: 1965
Nationality: Belgian
Eric has been with the company since 2002. He has many years of experience in global leadership roles at functional and/or business area level. He held various senior roles as GM of manufacturing site, as well as heading up various Global Business Units within our organisation. Before taking on his current role, he was President of the Surgical Division and later Executive Vice President, Global Operations & Regulatory Affairs and Quality Assurance. He has also worked across various industries.
Our Board
Mölnlycke Health Care is owned (99%) by Patricia Industries - a part of Investor AB. We operate under a board of directors consisting of seven members and one deputy. The board consists of five independent members, our CEO, one member from Investor AB and one deputy. The chairman is one of the independent board members.
Investor AB has owned Mölnlycke since 2007
Investor AB
Investor AB is a leading owner of Nordic-based international companies, founded by the Wallenberg family in 1916.
